Chitosan gel for planting restoration
Patent Information
- Application Number
- CN202411169567.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-24
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the material cannot simultaneously have lubrication effect and prevent microbial penetration for a long time, resulting in friction and infection at the screw connections during implantation and repair.
Using a preparation method including chitosan gel, by dissolving chitosan powder in acetic acid solution, adding pulp growth factor and antibacterial agent, heating, condensing and drying, finally immersing in DMEM culture medium In addition, polyvinyl alcohol is added to the gel to form a gel with lubricating and antibacterial properties.
It improves the application value and antibacterial performance in gingival restoration, enhances the stability and durability of the gel, and can quickly gel and fix drugs in a short time, extend the drug release time, and prevent bacterial infection.
Smart Images

Figure CN119015213A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of preparation of chitosan gel, in particular to chitosan gel for implant repair. Background Art
[0002] Oral implant restoration has become a common method for restoring missing teeth, but mechanical and biological complications still occur. Implant restoration includes a root-shaped implant and an upper restoration implanted in the bone. The upper restoration is connected to the implant through an abutment and a retaining screw. Screw loosening is one of the most important complications of implant restoration. The use of lubricants at the implant-prosthesis-abutment screw connection can reduce the friction coefficient between them, obtain a greater screw elongation, gradually increase the preload, and ultimately improve the stability of the implant-abutment connection.
[0003] There are micro gaps at the interface between the implant and the restoration abutment, which provide channels for microorganisms to leak inside and outside the implant and cause micro-movement of the implant components. There are viable microorganisms inside the implant and the abutment, which may lead to infection of the tissues near the installed implant and the abutment.
[0004] Candida albicans can be found in peri-implant biofilms where it binds to bacteria that have already colonized foreign matter and thus becomes part of a mature bacterial biofilm. In addition to colonizing the external implant surface, bacteria can also colonize the implant-prosthesis-abutment screw connection interface, particularly in the micro-gaps between the implant and the abutment. Microorganisms that colonize the external surface can be eliminated by host defense mechanisms, however, microorganisms that colonize the implant-abutment interface can persist internally for a long time, leading to unpleasant odor and taste, infection, and tissue damage.
[0005] Gutta-percha, Gap-Seal gel, polytetrafluoroethylene materials, chlorhexidine varnish and silicone sealants and composite resins have been used to study the sealing effect on implant-prosthesis-abutment screw connections. Although these materials show good results, they cannot also have a lubricating effect and only prevent microbial penetration for a short time. For this reason, a chitosan gel for implant restoration is proposed.
[0006] The above information disclosed in this background technology is only used to increase the understanding of the background technology of the present invention and therefore, it may include information that does not constitute the prior art known to ordinary technicians in this field. Summary of the invention
[0007] The present invention aims to solve at least one of the problems existing in the prior art, that is, the material cannot have lubrication effect at the same time and can only prevent microbial penetration for a short time. To this end, one object of the present invention is to provide a chitosan gel for implant repair.
[0008] To achieve the above object, the present invention provides the following technical solutions:
[0009] A chitosan gel for implant repair comprises the following steps:
[0010] S1. First, take 3g of chitosan powder, add it to 1% acetic acid solution, stir it thoroughly to make it completely dissolved, and the concentration of chitosan obtained by stirring is between 1-3%. Sterilize the chitosan solution in a sterilizer for 10 minutes, take it out and place it in a sterile box;
[0011] S2, pouring the chitosan solution into water at 60-80° C. and heating it for 30-60 min to completely dissolve the chitosan to obtain a chitosan solution;
[0012] S3, adding 50-100 μg / ml of dental pulp growth factor and 0.1-1% of antibacterial agent to the chitosan solution, and stirring the solution thoroughly to make the dental pulp growth factor and antibacterial agent evenly distributed in the chitosan solution;
[0013] S4, cooling the heated chitosan solution at room temperature, and then placing it in a freezer for solidification to obtain chitosan gel, the solidification time is 12-24 hours, and the internal temperature of the freezer is set to 4°C;
[0014] S5, taking out the solidified chitosan gel, washing it with deionized water to remove residual acetic acid, and then drying it in a vacuum drying oven to obtain chitosan gel;
[0015] S6, adding chitosan gel to DMEM culture medium containing 100 mL / L fetal bovine serum, maintaining at 37° C. for 24 h, to prepare a chitosan gel extract;
[0016] S7. Add polyvinyl alcohol into the chitosan gel and stir until it is uniformly stirred.
[0017] As a further optimization scheme of the present invention, the preparation of chitosan powder comprises the following steps:
[0018] S1. Prepare high-purity chitosan, soak the chitosan raw material in dilute hydrochloric acid, and perform decalcification treatment;
[0019] S2, soaking the decalcified chitosan raw material in dilute sodium hydroxide for deproteinization, and soaking the deproteinized chitosan raw material in hydrogen peroxide for decolorization;
[0020] S3, soaking the decolorized chitosan raw material in dilute sodium hydroxide for deacetylation to obtain chitosan;
[0021] S4, deacetylation treatment is performed on the obtained chitosan to hydrolyze the acetyl groups in the chitosan, thereby obtaining deacetylated chitosan;
[0022] S5, centrifuging the deacetylated chitosan solution to separate the solid and liquid in the solution;
[0023] S6, washing the chitosan solid obtained after centrifugation with distilled water until the pH value of the washing solution is close to 7 to remove residual alkali;
[0024] S7, drying the washed chitosan with hot air to remove moisture inside and on the surface of the chitosan;
[0025] S8. Using a pulverizer to grind the dried chitosan, and screening the grinded chitosan to obtain chitosan with uniform particle size.
[0026] As a further optimization scheme of the present invention, in step S3, the dental pulp growth factor is BMP-2, and the antibacterial agent is an antibiotic.
[0027] As a further optimization scheme of the present invention, in step S1, the concentration of chitosan is 1.3%, and the concentration of dilute hydrochloric acid is 1m.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] The present invention adds pulp growth factor to the chitosan solution, which can promote the growth and repair of the pulp, improve the repair effect, and further improve the application value of chitosan gel in gum repair. In addition, an antibacterial agent is added to the chitosan solution to improve the antibacterial property of the chitosan gel, prevent bacterial infection, and further improve the repair effect. Similarly, polyvinyl alcohol is added to the chitosan gel to improve the stability and durability of the chitosan gel, which can quickly gel in a short time, so that the drug is fixed in the oral cavity and releases the drug property after fixation.
[0030] The above summary is for illustrative purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present invention will be readily apparent by reference to the accompanying drawings and the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The present invention is a flow chart of the preparation of chitosan gel. DETAILED DESCRIPTION
[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0033] Cut part of the gingival tissue and put it into the DMEM culture medium containing double antibodies. After repeated washing with the culture medium for 5 times, cut it into 2mmx2mmx2mm tissue blocks. Use a probe to evenly distribute it on the bottom of a 25mL culture bottle. Invert the culture bottle, add 5mL of DMEM culture medium containing 100mg / L fetal bovine serum, 100mg / L penicillin and 100mg / L streptomycin, place it in a CO2 incubator, and culture it at 37℃, 5% CO2 for 4h. When the tissue block adheres to the wall, flip the culture bottle and continue to culture. Change the DMEM culture medium once every 3d. When the cells reach the confluence point, digest them with 2.5g / L trypsin and pass them at 1:2. The primary cultured GFCs were passed to the third generation, and the cells were digested with 2.5g / L trypsin and passed to the fifth generation.
[0034] The preparation of chitosan powder comprises the following steps:
[0035] S1. Prepare high-purity chitosan, soak the chitosan raw material in dilute hydrochloric acid, and perform decalcification treatment;
[0036] S2, soaking the decalcified chitosan raw material in dilute sodium hydroxide for deproteinization, and soaking the deproteinized chitosan raw material in hydrogen peroxide for decolorization;
[0037] S3, soaking the decolorized chitosan raw material in dilute sodium hydroxide for deacetylation to obtain chitosan;
[0038] S4, deacetylation treatment is performed on the obtained chitosan to hydrolyze the acetyl groups in the chitosan, thereby obtaining deacetylated chitosan;
[0039] S5, centrifuging the deacetylated chitosan solution to separate the solid and liquid in the solution;
[0040] S6, washing the chitosan solid obtained after centrifugation with distilled water until the pH value of the washing solution is close to 7 to remove residual alkali;
[0041] S7, drying the washed chitosan with hot air to remove moisture inside and on the surface of the chitosan;
[0042] S8. Using a pulverizer to grind the dried chitosan, and screening the grinded chitosan to obtain chitosan with uniform particle size.
[0043] A chitosan gel for implant repair comprises the following steps:
[0044] S1. First, take 3g of chitosan powder, add it to 1% acetic acid solution, stir it thoroughly to make it completely dissolved, the concentration of chitosan obtained by stirring is between 1-3%, sterilize the chitosan solution in a sterilizer for 10min, take it out and place it in a sterile box, wherein the concentration of chitosan is 1.3%, and the concentration of dilute hydrochloric acid is 1m;
[0045] S2, pouring the chitosan solution into water at 60-80° C. and heating it for 30-60 min to completely dissolve the chitosan to obtain a chitosan solution;
[0046] S3, adding 50-100 μg / ml of dental pulp growth factor and 0.1-1% of antibacterial agent to the chitosan solution, and stirring the solution sufficiently to make the dental pulp growth factor and the antibacterial agent evenly distributed in the chitosan solution, wherein the dental pulp growth factor is BMP-2 and the antibacterial agent is an antibiotic;
[0047] S4, cooling the heated chitosan solution at room temperature, and then placing it in a freezer for solidification to obtain chitosan gel, the solidification time is 12-24 hours, and the internal temperature of the freezer is set to 4°C;
[0048] S5, taking out the solidified chitosan gel, washing it with deionized water to remove residual acetic acid, and then drying it in a vacuum drying oven to obtain chitosan gel;
[0049] S6, adding chitosan gel to DMEM culture medium containing 100 mL / L fetal bovine serum, maintaining at 37° C. for 24 h, to prepare a chitosan gel extract;
[0050] S7. Add polyvinyl alcohol into the chitosan gel and stir until it is uniformly stirred.
[0051] The prepared chitosan gel was applied to GFCs, and the effect of thermosensitive chitosan hydrogel on the proliferation of GFCs was studied. The fifth generation cells were digested and centrifuged and then blown into a single cell suspension with DMEM culture medium containing 100 mg / L fetal bovine serum. The cell concentration was adjusted to 2x105 / mL using a cell counting plate and inoculated into 96-well plates. There were 10 plates in total, and 0.1 mL was added to each well. After culturing for 24 hours, most of the GFCs were observed to be attached to the wall and stretched under a microscope. 0.1 mL of the extract was added to each well to make the final concentration in the well reach 25, 5, 1 times and 10% of the standard concentration, respectively. Each concentration of the extract was added to 7 wells, and 0.1 mL of the culture medium was added to the blank control group. The 96-well plate was cultured at 37°C and 5% CO2 by volume. One culture plate was taken out at 24, 48, 72, and 96 hours, respectively, and 20 μL of 5 g / L MTT was added to each well and cultured for another 4 hours. The culture medium in the wells was aspirated, and 150 μL of DMSO was added to each well. The wells were oscillated for 10 minutes, and the absorbance (A) value was measured at a wavelength of 490 nm using an enzyme reader to reflect its effect on cell proliferation.
[0052] The following table compares the A values obtained by each group of MTTA:
[0053] Group 24H 48H 72H Blank control group 0.25±0.02 0.25±0.04 0.37±0.01 25 times group 0.24±0.01 0.40±0.02 0.55±0.02 5x group 0.25±0.02 0.49±0.03 0.58±0.01 1x group 0.24±0.01 0.46±0.01 0.50±0.01 10% concentration group 0.26±0.01 0.28±0.01 0.34±0.02
[0054] The following table compares the A values obtained for each group of ALP:
[0055] Group 24H 48H 72H Blank control group 0.45±0.02 0.58±0.02 0.75±0.03 25 times group 0.41±0.02 0.55±0.02 0.73±0.02 5x group 0.42±0.02 0.53±0.03 0.66±0.04 1x group 0.44±0.01 0.20±0.01 0.65±0.02 10% concentration group 0.41±0.01 0.57±0.02 0.69±0.02
[0056] From the above, it can be seen that after 24 hours of culture, the extracts of each group promoted the proliferation and ALP activity of human GFCs.
[0057] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example" or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, unless they are contradictory.
[0058] Parts not involved in the present invention are the same as the prior art or can be implemented by the prior art. Although the embodiments of the present invention have been shown and described, it is understood by those skilled in the art that various changes, modifications, substitutions and variations can be made to these embodiments without departing from the principles and spirit of the present invention, and the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A chitosan gel for implant repair, characterized in that: The following steps are involved: S1. First, take 3g of chitosan powder, add it to 1% acetic acid solution, and stir thoroughly to completely dissolve it. The concentration of chitosan obtained by stirring is between 1-3%. Sterilize the chitosan solution in a sterilizer for 10 minutes, take it out and place it in a sterile box; S2. Pour the chitosan solution into water at 60-80° C. and heat for 30-60 min to completely dissolve the chitosan to obtain a chitosan solution; S3. Add 50-100 μg / ml of dental pulp growth factor and 0.1-1% of antibacterial agent to the chitosan solution, and stir thoroughly to evenly distribute the dental pulp growth factor and antibacterial agent in the chitosan solution; S4, cooling the heated chitosan solution at room temperature, and then placing it in a freezer for solidification to obtain chitosan gel. The solidification time is 12-24 hours, and the internal temperature of the freezer is set to 4°C; S5. Taking out the solidified chitosan gel, washing it with deionized water to remove residual acetic acid, and then drying it in a vacuum drying oven to obtain a chitosan gel; S6. Add the chitosan gel to a DMEM culture medium containing 100 mL / L fetal bovine serum and maintain at 37° C. for 24 h to prepare a chitosan gel extract; S7. Add polyvinyl alcohol into the chitosan gel and stir until it is uniform.
2. The chitosan gel for implant restoration according to claim 1, characterized in that: The preparation of chitosan powder comprises the following steps: S1. Prepare high-purity chitosan and soak the chitosan raw material in dilute hydrochloric acid for decalcification; S2, soaking the decalcified chitosan raw material in dilute sodium hydroxide for deproteinization, and soaking the deproteinized chitosan raw material in hydrogen peroxide for decolorization; S3, soaking the decolorized chitosan raw material in dilute sodium hydroxide and performing deacetylation treatment to obtain chitosan; S4, deacetylation treatment is performed on the obtained chitosan to hydrolyze the acetyl groups in the chitosan, thereby obtaining deacetylated chitosan; S5, centrifuging the deacetylated chitosan solution to separate the solid and liquid in the solution; S6. Washing the chitosan solid obtained after centrifugation with distilled water until the pH value of the washing solution is close to 7 to remove residual alkali; S7, drying the washed chitosan with hot air to remove moisture from the interior and surface of the chitosan; S8. Using a pulverizer to grind the dried chitosan, and screening the grinded chitosan to obtain chitosan with uniform particle size.
3. The chitosan gel for implant restoration according to claim 1, characterized in that: In step S3, the dental pulp growth factor is BMP-2, and the antibacterial agent is an antibiotic.
4. The chitosan gel for implant restoration according to claim 2, characterized in that: In step S1 , the concentration of chitosan is 1.3% and the concentration of dilute hydrochloric acid is 1 M.
